Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 11 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2 Sleep Wake Disorders 1 Fatty Liver 1 Fatigue 1 Endometrial Adenocarcinoma 1 Depression 1 Colorectal Neoplasms 1 Breast Neoplasms, Male 1

Interventions

Fluorouracil 29 Leucovorin 26 Oxaliplatin 25 Capecitabine 16 Irinotecan 14 Cetuximab 10 Bevacizumab 9 Radiotherapy 8 Panitumumab 5 Folfox protocol 5 Surgical Procedures, Operative 3 Levamisole 3 Celecoxib 3 tremelimumab 2 neratinib 2 napabucasin 2 durvalumab 2 cediranib 2 aflibercept 2 X-Rays 2 Tegafur 2 Radiofrequency Ablation 2 Psychiatric Rehabilitation 2 Preoperative Exercise 2 Octreotide 2 Mitomycin 2 Interviews as Topic 2 Immunoglobulin G 2 Folic Acid 2 Floxuridine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Colorectal Neoplasms × Metformin × Clear all

NCT01523639 2018-12-19

G-LUCAS

Austrian Breast & Colorectal Cancer Study Group

Phase 2 Terminated

Gastrointestinal

Fatty Liver, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡